The cancer drug was hailed a wonder drug for chronic myeloid leukemia patients when it was approved by the FDA in 2011. Now, study found 83 percent of patients who used it as initial therapy were alive 10 years after diagnosis.
The cancer drug was hailed a wonder drug for chronic myeloid leukemia patients when it was approved by the FDA in 2011. Now, study found 83 percent of patients who used it as initial therapy were alive 10 years after diagnosis.
Please to comment